Nexalin Technology (NXL) Operating Leases (2021 - 2023)
Nexalin Technology's (NXL) quarterly Operating Leases came in at $43026.0 in Q1 2023, up 864.06% quarter-over-quarter from $4463.0 in Q4 2022.
Nexalin Technology (NXL) Operating Leases (2021 - 2023) Analysis & Trends
Nexalin Technology's Operating Leases history runs 3 years deep, the most recent figure standing at $43026.0 for Q1 2023.
- On a quarterly basis, Operating Leases changed N/A year-over-year to $43026.0 in Q1 2023; TTM through Mar 2023 was $43026.0, a N/A change from a year earlier, with the FY2022 full-year figure at $4463.0, down 95.04% from the prior year.
- Operating Leases rose to $43026.0 in Q1 2023 per NXL's latest filing, from $4463.0 in the prior quarter.
- Across five years, Operating Leases topped out at $89934.0 in Q4 2021 and bottomed at $4463.0 in Q4 2022.
- The 3-year median for Operating Leases is $30330.0 (2022), against an average of $38764.2.
- Biggest YoY gain for Operating Leases was 95.04% in 2022; the steepest drop was 95.04% in 2022.
- Year by year, Operating Leases stood at $89934.0 in 2021, then tumbled by 95.04% to $4463.0 in 2022, then jumped by 864.06% to $43026.0 in 2023.
- Per Business Quant, the three latest NXL Operating Leases figures stand at $43026.0 (Q1 2023), $4463.0 (Q4 2022), and $17634.0 (Q3 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Nexalin Technology | 9.32 Mn | 6.61 Mn | 13,133.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 43,026.00 |
| Dec 31, 2022 | 4,463.00 |
| Sep 30, 2022 | 17,634.00 |
| Dec 31, 2021 | 89,934.00 |